Ʊ-Site Updates
/index.html
English News Release,Information,Latest News.REVENUE OF LEQEMBI® (PRELIMINARY BASIS)
/news/2025/news202534.html
Ʊ's news release REVENUE OF LEQEMBI® (PRELIMINARY BASIS) is posted. 2025-05-01T19:45:00+09:00Ʊ Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star
/news/2025/news202533.html
Ʊ's news release Ʊ Representative Corporate Officer and CEO Haruo Naito Awarded the Order of the Rising Sun, Gold and Silver Star is posted. 2025-04-29T08:30:00+09:00Recent hhc Activities “Socialization with Systemic Sclerosis Patients by Ʊ’s Sustainability Department ー Interaction with Peers and Raising Disease Awareness of People Surrounding Patients Improves the Patient Environment”
/hhc/activity/089.html
Ʊ's latest news Recent hhc Activities “Socialization with Systemic Sclerosis Patients by Ʊ’s Sustainability Department ー Interaction with Peers and Raising Disease Awareness of People Surrounding Patients Improves the Patient Environment” is posted. 2025-04-24T16:26:28+09:00Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
/news/2025/news202532.html
Ʊ's news release Leqembi® (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union is posted. 2025-04-16T08:00:00+09:00Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission
/news/2025/news202531.html
Ʊ's news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-14T21:30:00+09:00IR "Renewal of Investor Relations section launched on corporate website"
/ir/index.html
Ʊ's latest news IR "Renewal of Investor Relations section launched on corporate website" is posted. 2025-04-07T18:00:07+09:00Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission
/news/2025/news202530.html
Ʊ's news release Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission is posted. 2025-04-01T19:00:00+09:00“New Answers to Dementia” Ʊ Launches Corporate Awareness Campaign
/news/2025/news202528.html
Ʊ's news release “New Answers to Dementia” Ʊ Launches Corporate Awareness Campaign is posted. 2025-03-28T11:00:00+09:00EISAI TO DIVEST RIGHTS FOR PARIET® IN CHINA TO PEAK PHARMA
/news/2025/news202527.html
Ʊ's news release EISAI TO DIVEST RIGHTS FOR PARIET® IN CHINA TO PEAK PHARMA is posted. 2025-03-28T08:30:00+09:00Ʊ to Divest Rights for Warfarin in Japan to Sawai
/news/2025/news202526.html
Ʊ's news release Ʊ to Divest Rights for Warfarin in Japan to Sawai is posted. 2025-03-27T13:00:00+09:00IR “Information Meeting 2025 (Material, webcast)”
/ir/library/presentations/index.html
Ʊ's latest news IR “Information Meeting 2025 (Material, webcast)” is posted. 2025-03-27T09:00:00+09:00Ʊ to Present the Latest Research Results, Including Long-Term and Real-Word Data on Lecanemab and Biomarkers for Alzheimer’s Disease at the AD/PD™ 2025 Annual Meeting
/news/2025/news202525.html
Ʊ's news release Ʊ to Present the Latest Research Results, Including Long-Term and Real-Word Data on Lecanemab and Biomarkers for Alzheimer’s Disease at the AD/PD™ 2025 Annual Meeting is posted. 2025-03-27T08:30:00+09:00IR “Presentation Material for Press Conference 2025”
/ir/library/presentations/index.html
Ʊ's latest news IR “Presentation Material for Press Conference 2025” is posted. 2025-03-25T15:35:20+09:00World’s First Early Alzheimer’s Disease Treatment Developed in Japan LEQEMBI® Receives Prime Minister’s Award at the 12th Technology Management and Innovation Awards
/news/2025/news202524.html
Ʊ's news release World’s First Early Alzheimer’s Disease Treatment Developed in Japan LEQEMBI® Receives Prime Minister’s Award at the 12th Technology Management and Innovation Awards is posted. 2025-03-25T10:00:00+09:00EISAI SELECTED AS A NADESHIKO BRAND 2025 AS A LISTED COMPANY EXCELLING IN PROMOTION OF WOMEN IN THE WORKPLACE
/news/2025/news202523.html
Ʊ's news release EISAI SELECTED AS A NADESHIKO BRAND 2025 AS A LISTED COMPANY EXCELLING IN PROMOTION OF WOMEN IN THE WORKPLACE is posted. 2025-03-24T14:20:19+09:00